|
시장보고서
상품코드
2055081
단편 분석 시장 : 기술별, 제품 및 서비스별, 프래그먼트 유형별, 용도별Fragment Analysis Market, By Technology, By Product and Service, By Fragment Type, By Application (Nucleic Acid Analysis, Quality Control and Validation, By End User,By Geography ) |
||||||
단편 분석 시장은 2026년에 3억 940만 달러로 추정되며, 2033년까지 6억 300만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 10.0%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 3억 940만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.00% | 2033년 시장 규모 예측 : | 6억 300만 달러 |
단편 분석은 DNA 및 RNA 단편의 크기와 분자적 특성을 바탕으로 이를 정밀하게 분리, 동정 및 정량할 수 있게 해주는 첨단 분자생물학 기술입니다. 이 분석 기법은 유전체학, 단백체학, 법의학, 임상 진단, 제약 연구 등 다양한 과학 분야에서 필수적인 요소로 자리 잡고 있습니다. 전 세계 단편 분석 시장은 뛰어난 정확성과 효율성으로 고해상도 유전자 분석을 가능하게 하도록 설계된 장비, 시약, 소모품 및 소프트웨어 솔루션을 종합적으로 다루고 있습니다.
단편 분석 기술은 모세관 전기영동, 자동 염기서열 분석 플랫폼 및 첨단 검출 시스템을 활용하여, 마이크로위성 분석, 이형접합성 상실(LOH) 연구, 비교 유전체 하이브리다이제이션, 단일 염기 다형성(SNP) 검출 등의 응용 분야에서 필수적인, 상세한 분자 수준의 인사이트를 연구자 및 임상의에게 제공합니다. 이 시장은 맞춤형 의료에 대한 수요 증가, 암 연구 분야의 응용 범위 확대, 유전성 질환 유병률 상승, 그리고 분석 장비의 지속적인 기술 발전에 힘입어 눈부신 성장을 이루고 있습니다. 전 세계 의료 시스템이 정밀 의학 및 표적 치료 접근법을 우선시하는 가운데, 단편 분석은 유전적 변이 이해, 질병 바이오마커 식별, 그리고 새로운 치료법 개발의 핵심 기반 기술로 부상하고 있으며, 다양한 연구 개발 및 임상 환경에서 이 시장의 지속적인 성장이 예상됩니다.
시장 역학
세계 파편화 분석 시장은 성장 궤도를 이어가며 여러 분야에 걸쳐 적용 범위를 확대하고 있는 가운데, 몇 가지 강력한 촉진요인에 힘입어 성장하고 있습니다. 주요 성장 요인은 유전체 연구 및 맞춤형 의료 분야의 급속한 성장에 기인하며, 단편 분석은 표적 치료 전략 및 진단 프로토콜 개발에 필수적인 유전적 변이, 돌연변이 및 다형성을 규명하는 데 중요한 역할을 하고 있습니다. 전 세계적으로 유전성 질환 및 암의 유병률이 증가함에 따라 정밀한 분자진단 도구에 대한 수요가 크게 높아지고 있으며, 단편 분석은 복잡한 유전학 연구와 임상적 의사 결정에 필요한 정확도와 분해능을 연구자와 임상의에게 제공합니다.
모세관 전기영동 시스템, 자동화 플랫폼 및 고처리량 시퀀싱 기술의 발전으로 인해 단편 분석 과정의 효율성, 속도 및 비용 효율성이 향상되어, 연구 기관, 임상 실험실 및 제약 기업에서 이러한 솔루션을 더욱 쉽게 활용할 수 있게 되었습니다.
그러나 시장에는 첨단 파편 분석 장치에 필요한 막대한 초기 투자 비용, 전문적인 기술 지식이 요구되는 복잡한 운영 요건, 그리고 신기술의 제품 승인 및 시장 진입을 지연시킬 수 있는 엄격한 규제 준수 기준 등 뚜렷한 제약 요인들이 존재합니다.
또한, 대체 분석 기법의 등장과 신흥 시퀀싱 기술과의 경쟁 역시 시장 확대에 있어 과제로 대두되고 있습니다. 이러한 제약이 있음에도 불구하고, 신흥 경제국에서의 단편 분석 도입 확대, 농업 유전체학 및 환경 모니터링 분야로의 응용 확대, 유전체학 연구 프로그램에 대한 정부 자금 지원 증가, 그리고 다양한 실험실 환경과 지리적 지역에서 첨단 분자 분석 기능에 대한 접근성을 높이는 휴대용 및 사용하기 쉬운 장비의 개발 등, 큰 기회가 존재하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 파편화 분석 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 단편 분석 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 파편화 분석 시장에 대한 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 단편 분석 시장 : 기술별, 2021년-2033년
제5장 세계의 단편 분석 시장 : 제품 및 서비스별, 2021년-2033년
제6장 세계의 단편 분석 시장 : 프래그먼트 유형별, 2021년-2033년
제7장 세계의 단편 분석 시장 : 용도별, 2021년-2033년
제8장 세계의 단편 분석 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 단편 분석 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.22Fragment Analysis Market is estimated to be valued at USD 309.4 Mn in 2026 and is expected to reach USD 603.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 309.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.00% | 2033 Value Projection: | USD 603 Mn |
Fragment analysis represents a sophisticated molecular biology technique that enables precise separation, identification, and quantification of DNA and RNA fragments based on their size and molecular characteristics. This analytical method has become indispensable in various scientific disciplines, including genomics, proteomics, forensics, clinical diagnostics, and pharmaceutical research. The global fragment analysis market encompasses a comprehensive range of instruments, reagents, consumables, and software solutions designed to facilitate high-resolution genetic analysis with exceptional accuracy and efficiency.
Fragment analysis technologies utilize capillary electrophoresis, automated sequencing platforms, and advanced detection systems to provide researchers and clinicians with detailed molecular insights essential for applications such as microsatellite analysis, loss of heterozygosity studies, comparative genomic hybridization, and single nucleotide polymorphism detection. The market has witnessed substantial growth driven by increasing demand for personalized medicine, expanding applications in cancer research, rising prevalence of genetic disorders, and continuous technological advancements in analytical instrumentation. As healthcare systems worldwide prioritize precision medicine and targeted therapeutic approaches, fragment analysis has emerged as a critical enabler for understanding genetic variations, identifying disease biomarkers, and developing novel therapeutic interventions, positioning this market for sustained expansion across diverse research and clinical environments.
Market Dynamics
The global fragment analysis market is propelled by several compelling drivers that continue to shape its growth trajectory and expand its applications across multiple sectors. The primary driver stems from the exponential growth in genomics research and personalized medicine initiatives, where fragment analysis plays a crucial role in identifying genetic variations, mutations, and polymorphisms essential for developing targeted therapeutic strategies and diagnostic protocols. The increasing prevalence of genetic disorders and cancer worldwide has significantly amplified the demand for precise molecular diagnostic tools, with fragment analysis providing researchers and clinicians with the accuracy and resolution required for complex genetic studies and clinical decision-making.
Technological advancements in capillary electrophoresis systems, automated platforms, and high-throughput sequencing technologies have enhanced the efficiency, speed, and cost-effectiveness of fragment analysis procedures, making these solutions more accessible to research institutions, clinical laboratories, and pharmaceutical companies.
However, the market faces notable restraints including high initial capital investments required for advanced fragment analysis instruments, complex operational requirements demanding specialized technical expertise, and stringent regulatory compliance standards that can delay product approvals and market entry for new technologies.
Additionally, the availability of alternative analytical methods and competition from emerging sequencing technologies pose challenges to market expansion. Despite these constraints, significant opportunities exist in the growing adoption of fragment analysis in emerging economies, expanding applications in agricultural genomics and environmental monitoring, increasing government funding for genomics research programs, and the development of portable, user-friendly instruments that can democratize access to sophisticated molecular analysis capabilities across diverse laboratory settings and geographical regions.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global fragment analysis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, PerkinElmer Inc. (Revvity), Merck KGaA (MilliporeSigma), F. Hoffmann-La Roche Ltd., Illumina Inc., Abbott Laboratories, New England Biolabs Inc., Takara Bio Inc., SCIEX, and LGC Group
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global fragment analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fragment analysis market
Market Segmentation
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Polymerase Chain Reaction (PCR)-Based Fragment Analysis
- Capillary Electrophoresis (CE)
- Next-Generation Sequencing (NGS)-Based Fragment Analysis
- Microfluidics and Lab-on-Chip Fragment Analysis
- Gel Electrophoresis (Agarose/Polyacrylamide)
- Product and Service Insights (Revenue, USD Mn, 2021 - 2033)
- Instruments
- Genetic Analyzers/Sequencers
- PCR Systems
- Microarray Scanners
- Other Instruments
- Consumables and Reagents
- Kits and Assays
- Enzymes and Master Mixes
- Standards and Size Markers
- Other Reagents
- Software and Services
- Fragment Type Insights (Revenue, USD Mn, 2021 - 2033)
- DNA Fragments
- RNA Fragments
- Protein Fragments (Low-use, niche applications)
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Nucleic Acid Analysis
- Genotyping (SSR, SNP)
- Mutation Detection and Sequencing
- Others (Microsatellite Instability Analysis, etc.)
- Quality Control and Validation
- Next-Generation Sequencing Library QC
- CRISPR Edit Confirmation
- Others (PCR Product Verification, etc.)
- Genetic Fingerprinting and Forensics
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Clinical Diagnostics Laboratories
- Hospitals
- Research and Academic Institutes
- Biopharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Promega Corporation
- PerkinElmer Inc. (Revvity)
- Merck KGaA (MilliporeSigma)
- Hoffmann-La Roche Ltd.
- Illumina Inc.
- Abbott Laboratories
- New England Biolabs Inc.
- Takara Bio Inc.
- SCIEX
- LGC Group
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Fragment Analysis Market, By Technology
- Global Fragment Analysis Market, By Product and Service
- Global Fragment Analysis Market, By Fragment Type
- Global Fragment Analysis Market, By Application
- Global Fragment Analysis Market, By End User
- Global Fragment Analysis Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Fragment Analysis Market, By Technology, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Polymerase Chain Reaction (PCR)-Based Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Capillary Electrophoresis (CE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Next-Generation Sequencing (NGS)-Based Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Microfluidics and Lab-on-Chip Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Gel Electrophoresis (Agarose/Polyacrylamide)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Fragment Analysis Market, By Product and Service, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Genetic Analyzers/Sequencers
- PCR Systems
- Microarray Scanners
- Other Instruments
- Consumables and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Kits and Assays
- Enzymes and Master Mixes
- Standards and Size Markers
- Other Reagents
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Fragment Analysis Market, By Fragment Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- DNA Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- RNA Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Protein Fragments (Low-use, niche applications)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Fragment Analysis Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Nucleic Acid Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Genotyping (SSR, SNP)
- Mutation Detection and Sequencing
- Others (Microsatellite Instability Analysis, etc.)
- Quality Control and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Next-Generation Sequencing Library QC
- CRISPR Edit Confirmation
- Others (PCR Product Verification, etc.)
- Genetic Fingerprinting and Forensics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Fragment Analysis Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biopharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Fragment Analysis Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer Inc. (Revvity)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SCIEX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LGC Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
